Categories
Uncategorized

Spinal metastases

Most prevalent neoplasms with spinal metastases are breast, lung, prostate, kidney tumors and lymphoma.

Most common site for bone metastases.

Almost 40% of patients with cancer develop spinal metastasis during the course of their malignancy.

The thoracic spine, lumbar spine and cervical spine account for approximately 70%, 20% and 10% of spinal metastases, respectively.

Lesions can occur in the paraspinal region, bony vertebral column, epidural or subarachnoid spaces.

Vertebral collapse occurs in as many as 70% of patients with metastatic cancer and myeloma.

The risk of vertebral fracture is 5 fold greater in patients with recently diagnosed breast cancer and 36 fold greater with a soft tissue recurrence compared to a woman without breast cancer.

Approximately 50% of lesions are clinically silent.

Pain is the presentation in 90% of patients.

Patients suffer with pain and may have neurological complications, including metastatic epidural spinal cord compression.

Pain secondary to nociceptors activation induced by periosteal stretching by the tumor, tumor induced nerve stimulation in the endosteum, osteolysis and acidotic microenvironment caused by apoptosis of cancer cells in the filled intramedullary space.

Untreated vertebral body compression fractures can lead to adjacent level collapse, spinal cord compromise, and intractable pain.

The risk of vertebral fracture is 5 fold greater in patients with recently diagnosed breast cancer and 36 fold greater with a soft tissue recurrence compared to a woman without breast cancer.

Can cause severe pain, pathologic fractures, hypercalcemia, spinal cord compression, neurologic symptoms, decreased bone density, decreased strength, and stiffness.

Can cause deformation of the vertebra, instability of the spine, kyphosis, and fracture.

Risk for new vertebral fractures related to the number and severity of vertebral deformities.

Diagnosis begins with physical examination and imaging with CT or MRI.
MRI is the imaging modality with the best discriminate capability, enabling visualization of structural changes and determination of the typical pattern of malignant involvement, depending upon the etiology.
Treatment choices include: surgery, radiation, and chemotherapy.
Management of spinal metastases goals include; pain relief, preservation or recovery of neurologic function, prevention of malignant epidural spinal cord compression and eradication of a limited number of volume of disease deposits.
Treatment modalities maybe combine and are rarely use alone.
Spinal surgery is generally for spinal metastasis presenting with symptomatic vertebral compression fractures, mechanical instability, and acute symptomatic malignant epidural spinal cord compression.
Treatment recommendations need to consider patient’s age and other medical conditions, tumor type, number of metastases, and whether.there is spinal cord compression.

Radiotherapy effectively controls pain for the majority of patients with spinal metastases.

High-dose radiotherapy, however that may be needed for durable tumor control and prevention of bone destruction of the spiral column is precluded by sensitivity of the sponal cord to radiation.

Avsingle fraction of conventional external been radiotherapy has comparable effectiveness to multifraction schedules for initial pain, and represents the recommended treatment approach for most patients with symptomatic uncomplicated spinal metastases.
Conventional external beam radiation tumor local control in pain relief is estimated approximately 60-80%, with delayed onset of 2 to 3 weeks and short median duration of pain relief of four months.

Conventional external beam radiation provides sub optimal rates of local control and pain relief for patients with longer life expectancies.

The use of conventional technique radiation therapy also precludes re-irradiation.

Stereo topic body radiation therapy for spinal lesions is an effective primary or salvage therapy for mechanically stable spinal metastases.

SBRT using image guidance can deliver high dose radiation precisely, with a steep dose gradient at the interface between spinal cord and tumor in spinal cord metastases, creating a therapeutic window by lowering the risk for spinal cord myelopathy.

In spinal metastases SBRT can be used instead of surgery, allowing patients to avoid perioperative risk factors such as bleeding infection and anesthesia.

Targeted radioablation therapy effective for pain palliation.

Leave a Reply

Your email address will not be published.